(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 13.77% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.75%.
Quanterix's revenue in 2026 is $144,979,000.On average, 5 Wall Street analysts forecast QTRX's revenue for 2026 to be $8,164,879,687, with the lowest QTRX revenue forecast at $7,810,642,710, and the highest QTRX revenue forecast at $8,477,663,401. On average, 5 Wall Street analysts forecast QTRX's revenue for 2027 to be $9,064,132,864, with the lowest QTRX revenue forecast at $8,504,513,810, and the highest QTRX revenue forecast at $9,481,962,915.
In 2028, QTRX is forecast to generate $10,075,969,336 in revenue, with the lowest revenue forecast at $9,265,746,463 and the highest revenue forecast at $10,733,097,771.